From The Motley Fool · Sara Appino · · 1m
Healthcare ETF Comparison: IXJ vs FBT
Which healthcare ETF offers better long-term growth: iShares' global healthcare fund or First Trust's biotech fund?
In brief
Which healthcare ETF offers better long-term growth: iShares' global healthcare fund or First Trust's biotech fund? iShares Global Healthcare ETF (IXJ) provides broader healthcare exposure with lower costs and stable returns, while First Trust's Biotech ETF (FBT) targets high-growth biotech stocks but carries higher…
ETF Comparison
iShares Global Healthcare ETF (IXJ) provides broad, lower-cost exposure to global health sectors, while First Trust NYSE Arca Biotechnology Index Fund (FBT) focuses on biotech firms.
Key Metrics
IXJ: $109.35 (1.32% yield), 0.38% expense ratio; FBT: $271.47 (0.83% gain), 0.55% expense ratio.
52-Week Range
IXJ: $90.28 - $110.78; FBT: $186.20 - $275.23.
Portfolio Structure
IXJ holds 109 healthcare companies across pharma, biotech, and medical services; FBT focuses on 30 biotech firms.
Performance History
IXJ grew $1,000 to $1,362 over 5 years; FBT grew $1,000 to $1,641 over 5 years.
Investor Suitability
IXJ suits long-term investors seeking stability; FBT targets those confident in biotech's growth potential.
The takeaway
iShares Global Healthcare ETF (IXJ) provides broader healthcare exposure with lower costs and stable returns, while First Trust's Biotech ETF (FBT) targets high-growth biotech stocks but carries higher risk.
